Abstract:Significance: Protein neddylation is catalyzed by an E1 NEDD8-activating enzyme (NAE), an E2 NEDD8-conjugating enzyme, and an E3 NEDD8 ligase. Known physiological substrates of neddylation are cullin family members. Cullin neddylation leads to activation of cullin-RING ligases (CRLs), the largest family of E3 ubiquitin ligases responsible for ubiquitylation and degradation of many key signaling/regulatory proteins. Thus, through modulating CRLs, neddylation regulates many biological processes, including cell cycle progression, signal transduction, and tumorigenesis. Given that NEDD8 is overexpressed and CRLs are abnormally activated in many human cancers, targeting protein neddylation, in general, and cullin neddylation, in particular, appears to be an attractive anticancer approach. Recent Advances: MLN4924, a small molecule inhibitor of NAE, was discovered that inactivates CRLs and causes accumulation of CRL substrates to suppress tumor cell growth both in vitro and in vivo. Promising preclinical results advanced MLN4924 to several clinical trials for anticancer therapy. Critical Issues: In preclinical settings, MLN4924 effectively suppresses tumor cell growth by inducing apoptosis, senescence, and autophagy, and causes sensitization to chemoradiation therapies in a cellular context-dependent manner. Signal molecules that determine the cell fate upon MLN4924 treatment, however, remain elusive. Cancer cells develop MLN4924 resistance by selecting target mutations. Future Directions: In the clinical side, several Phase 1b trials are under way to determine the safety and efficacy of MLN4924, acting alone or in combination with conventional chemotherapy, against human solid tumors. In the preclinical side, the efforts are being made to develop additional neddylation inhibitors by targeting NEDD8 E2s and E3s. Antioxid. Redox Signal. 21, 2383-2400.

The role of NEDD4 related HECT-type E3 ubiquitin ligases in defective autophagy in cancer cells: molecular mechanisms and therapeutic perspectives

NEDD4 E3 ligase: Functions and mechanism in human cancer

Cullin-RING ligases in regulation of autophagy

Insights Into the Biological Role of NEDD4L E3 Ubiquitin Ligase in Human Cancers

NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor

Expression and regulatory network of E3 ubiquitin ligase NEDD4 family in cancers

The many substrates and functions of NEDD4-1

NEDD4 and NEDD4L: Ubiquitin Ligases Closely Related to Digestive Diseases

E3 ubiquitin ligase HECW2: a promising target for tumour therapy

SCF beta-TRCP-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway

Nedd4 E3 ubiquitin ligase promotes cell proliferation and autophagy.

Protein neddylation and its role in health and diseases

NEDD8-conjugating Enzyme E2s: Critical Targets for Cancer Therapy

The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

Auto-ubiquitination of NEDD4-1 Recruits USP13 to Facilitate Autophagy through Deubiquitinating VPS34

The NEDD4-USP13 Axis Facilitates Autophagy Via Deubiquitinating PIK3C3

Protein Neddylation and Its Alterations in Human Cancers for Targeted Therapy.

Inactivation of the Cullin (CUL)-RING E3 Ligase by the NEDD8-activating Enzyme Inhibitor MLN4924 Triggers Protective Autophagy in Cancer Cells

Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy

Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways

Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases